Lazard Strengthens MedTech Advisory Bench with Citi Veteran
Event summary
- Pranjal Gambhir joins Lazard as Head of Medical Technology on September 28, 2026
- Gambhir brings 20 years of experience from Citi, covering multiple MedTech sub-sectors
- Lazard aims to deepen its MedTech coverage with this strategic hire
- Gambhir will advise on strategy and corporate development transactions in the sector
The big picture
Lazard's hire of Pranjal Gambhir underscores the growing importance of specialized sector coverage in financial advisory. The MedTech sector, characterized by rapid innovation and complex regulatory environments, demands deep expertise—a gap Gambhir's experience aims to fill. This move positions Lazard to compete more aggressively with other advisory firms in a sector ripe for consolidation and strategic realignment.
What we're watching
- Sector Coverage Expansion
- How Lazard's MedTech practice will scale with Gambhir's sub-sector expertise
- Competitive Dynamics
- Whether Citi's loss of Gambhir impacts its MedTech advisory capabilities
- Deal Flow Impact
- The pace at which Lazard can secure high-value MedTech transactions under Gambhir's leadership